首页> 美国卫生研究院文献>Toxicological Research >Subcutaneous Four-Week Repeated Dose Toxicity Studies of Rice Cell-Derived Recombinant Human Granulocyte-Macrophage Colony Stimulating Factor in Rats
【2h】

Subcutaneous Four-Week Repeated Dose Toxicity Studies of Rice Cell-Derived Recombinant Human Granulocyte-Macrophage Colony Stimulating Factor in Rats

机译:水稻细胞衍生的重组人粒细胞-巨噬细胞集落刺激因子在大鼠中的皮下四周重复剂量毒性研究

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Recombinant human granulocyte-macrophage colony stimulating factor (hGM-CSF) is a glycoprotein and hematopoietic growth factors that regulates the proliferation of myeloid precursor cells and activates mature granulocytes and macrophages. In a previous study, we reported that hGM-CSF could be produced in transgenic rice cell suspension culture, termed rhGM-CSF. In the present study, we examined the repeated dose toxicity of rhGM-CSF in SD rats. The repeated dose toxicity study was performed at each dose of 50 and 200 µg/kg subcutaneous administration of rhGM-CSF everyday for 28-days period. The results did not show any changes in food and water intake. There were also no significant changes in both body and organ weights between the control and the tested groups. The hematological and blood biochemical parameters were statistically not different in all groups. These results suggest that rhGM-CSF may show no repeated dose toxicity in SD rats under the conditions.
机译:重组人粒细胞-巨噬细胞集落刺激因子(hGM-CSF)是一种糖蛋白和造血生长因子,可调节髓样前体细胞的增殖并激活成熟的粒细胞和巨噬细胞。在先前的研究中,我们报道了hGM-CSF可以在转基因水稻细胞悬浮培养物中产生,称为rhGM-CSF。在本研究中,我们检查了rhGM-CSF在SD大鼠中的重复剂量毒性。每天两次分别以50和200 µg / kg剂量皮下注射rhGM-CSF进行重复剂量毒性研究,持续28天。结果没有显示食物和水的摄入量有任何变化。对照组和测试组之间的体重和器官重量也没有显着变化。在所有组中,血液学和血液生化参数均无统计学差异。这些结果表明,在该条件下,rhGM-CSF在SD大鼠中可能没有显示出重复的剂量毒性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号